Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β

Autor: Jamie L. Harden, Israel Coats, Raphaela Goldbach-Mansky, Chyi-Chia Richard Lee, Jacob D. Estes, Hong-Wei Sun, Leanne M. Johnson-Huang, Joseph G. Dolan, Michelle A. Lowes, Mayte Suárez-Fariñas, Hiroshi Mitsui, Nicole Plass, Inna Novitskaya, Pamela Aubert, Edward W. Cowen, Katherine C. Pierson
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Male
Anatomy and Physiology
Neutrophils
Biopsy
T-Lymphocytes
Interleukin-1beta
Gene Expression
Epigenesis
Genetic

0302 clinical medicine
Immune Physiology
Homeostasis
Child
Tissue homeostasis
Skin
0303 health sciences
Multidisciplinary
integumentary system
Allergy and Hypersensitivity
Caspase 1
3. Good health
030220 oncology & carcinogenesis
Child
Preschool

Cytokines
Medicine
Tumor necrosis factor alpha
Female
medicine.symptom
medicine.drug
Research Article
Signal Transduction
Adult
Adolescent
Immune Cells
Inflammatory Diseases
Science
Antigen presentation
CD11c
Inflammation
Dermatology
Biology
Autoimmune Diseases
03 medical and health sciences
Genetic Mutation
Antigens
CD

medicine
Genetics
Humans
030304 developmental biology
Anakinra
Macrophages
Immunity
Receptors
Interleukin-1

HLA-DR Antigens
Cryopyrin-Associated Periodic Syndromes
CCL20
Interleukin 1 Receptor Antagonist Protein
MicroRNAs
Langerhans Cells
Immunology
Genetics of Disease
Clinical Immunology
CD163
Zdroj: PLoS ONE, Vol 7, Iss 11, p e49408 (2012)
PLoS ONE
ISSN: 1932-6203
Popis: The autoinflammatory disorder, Neonatal-onset Multisystem Inflammatory Disease (NOMID) is the most severe phenotype of disorders caused by mutations in CIAS1 that result in increased production and secretion of active IL-1β. NOMID patients present with systemic and organ-specific inflammation of the skin, central nervous system and bone, and respond dramatically to treatment with IL-1 blocking agents. We compared the cellular infiltrates and transcriptome of skin biopsies from patients with NOMID (n = 14) before treatment (lesional (LS) and non-lesional (pre-NL) skin) and after treatment (post-NL) with the IL-1 blocker anakinra (recombinant IL-1 receptor antagonist, Kineret®, Swedish Orphan Biovitrum AB, SOBI), to normal skin (n = 5) to assess tissue responses in the context of untreated and treated disease. Abundant neutrophils distinguish LS skin from pre-NL and post-NL skin. CD11c(+) dermal dendritic cells and CD163(+) macrophages expressed activated caspase-1 and are a likely source of cutaneous IL-1 production. Treatment with anakinra led to the disappearance of neutrophils, but CD3(+) T cells and HLA-DR(+) cells remained elevated. Among the upregulated genes IL-6, IL-8, TNF, IL-17A, CCL20, and the neutrophil defensins DEFA1 and DEFA3 were differentially regulated in LS tissues (compared to normal skin). Important significantly downregulated pathways in LS skin included IL-1R/TLR signaling, type I and II cytokine receptor signaling, mitochondrial dysfunction, and antigen presentation. The differential expression and regulation of microRNAs and pathways involved in post-transcriptional modification were suggestive of epigenetic modification in the chronically inflamed tissue. Overall, the dysregulated genes and pathways suggest extensive "adaptive" mechanisms to control inflammation and maintain tissue homeostasis, likely triggered by chronic IL-1 release in the skin of patients with NOMID.
Databáze: OpenAIRE